Russian Federation announced earlier its plans to produce between 1.5 million and 2 million doses of its Sputnik-V by the end of the year, gradually increasing production to 6 million doses a month.
epa08675836 A Russian medical worker prepares a trial vaccine against COVID-19 for a volunteer in a post-registration phase of the test at outpatient hospital number 68 in Moscow, Russia, 17 September 2020.
The Egyptian holding company VACSERA is conducting its own trials on two Chinese-made vaccines, in cooperation with the Chinese government and the UAE healthcare company G42.
"It may take some time to reach a concrete decision on co-funding the vaccine trial".
The vaccine candidate was developed by the German Center for Infection Research (DZIF) and the pharmaceutical company IDT Biologika. "The SEC has sought revised protocol from Dr Reddy's lab along with more information and now Dr Reddy's lab has to furnish a fresh protocol to the DCGI", a Government official said.
Under the agreement, Bangladesh would get 100,000 doses of vaccine for free and get priority to purchase an adequate quantum of vaccines from the Chinese company.
The trials will start this month, initially in the capital, Caracas, he added.
The Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford COVID-19 vaccine candidate also is conducting Phase 2 and 3 human clinical trials of the candidate in India.
Since that initial announcement, three trials are up and running - and recruiting the thousands of people needed to ensure the safety and efficacy of COVID-19 vaccines.
The ministry earlier said they planned to carry out the clinical trial on healthcare professionals first in the seven designated hospitals as they are front liners.
"As a result, the demand for shark squalene could skyrocket, leading to a significant increase in the killing and harvesting of sharks for their livers", said Shark Allies.